"The Altix UV supercomputer will allow extremely large, diverse data sets to be processed quickly, enabling our researchers to correlate medical and biological data on an unprecedented scale", stated Dr. Rune Linding, cellular and molecular logic team leader at the ICR. "Eventually, this will lead to network-based cancer models that will be used to streamline the process of drug development."
SGI Altix UV supports up to 16 terabytes of global shared memory in a single system image. It remains highly efficient at scale for applications ranging from in-memory databases to a diverse set of data and compute-intensive HPC applications. As a result, Altix UV is the only hardware solution equipped to meet the vast data processing requirements of the ICR.
"Altix UV will allow HPC customers like the ICR to think differently and solve problems that cannot be solved on other HPC platforms", stated Rod Evans, vice president of sales for Northern Europe at SGI. "We are delighted to be working with the ICR to provide this unique technology required to process the huge amounts of cancer-related data generated in medical research."
"Systems biology demands massive integration of extremely large data sets. Large shared memory should enable us to handle such data at a much higher speed and with a greater focus on the biological questions at hand", stated Peter Rigby, chief executive professor at ICR. "Altix UV should significantly help our work in this new, exciting area of cancer research."
"With its upcoming SGI Altix UV deployment, the ICR will be at the forefront of HPC for biological research as it pursues treatments for cancer", stated Richard Dracott, general manager of high performance computing at Intel. "Altix UV will meaningfully transform HPC by drawing on large memory capacity, high core count and scalability of our forthcoming next generation Intel Xeon processor-based server platform, for the expandable server segments - codenamed Nehalem-EX."
The ICR is Europe's leading cancer research centre. The ICR has been ranked the United Kingdom's top academic research centre, based on the results of the Higher Education Funding Council's Research Assessment Exercise. The ICR works closely with partner the Royal Marsden NHS Foundation Trust to ensure patients immediately benefit from new research. Together the two organisations form the largest comprehensive cancer centre in Europe. The ICR has charitable status and relies on voluntary income, spending 95 pence in every pound of total income directly on research. As a college of the University of London, the ICR also provides postgraduate higher education of international distinction. Over its 100-year history, the ICR's achievements include identifying the potential link between smoking and lung cancer which was subsequently confirmed, discovering that DNA damage is the basic cause of cancer and isolating more cancer-related genes than any other organisation in the world.
SGI is a global expert in large-scale clustered computing, high performance storage, HPC and data centre enablement and services. SGI is focused on helping customers solve their most demanding business and technology challenges. More news on SGI and ICR is available in the VMW March 2009 article UK's Institute of Cancer Research and Silicon Graphics establish long-term alliance to design and outfit world-class Network Biology Lab.